Equities researchers at William Blair started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) in a research note issued to investors on Friday, Marketbeat reports. The firm ...
Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of MDxHealth in a research ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Structure Therapeutics Inc. - Depositary ...
We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) ...
William Blair upgraded shares of Zealand Pharma A/S (OTCMKTS:ZLDPF – Free Report) to a hold rating in a research note released on Thursday morning,Zacks.com reports. A number of other brokerages have ...
William Blair cut their FY2025 EPS estimates for Arhaus in a research note issued to investors on Wednesday, February 26th.
William Blair issued their Q1 2025 earnings per share (EPS) estimates for SoundThinking in a report issued on Wednesday, February 26th. William Blair analyst L. Dipalma expects that the company will ...
Stock analysts at William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of SES AI in a report released on Wednesday, February 26th. William Blair analyst J. Dorsheimer ...